The contribution of porins to enterobacterial drug resistance
Journal of Antimicrobial Chemotherapy · 01.10.2024 · 79 (10) · 2460-2470
DOI: 10.1093/jac/dkae265 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 29.08.2024. Verfasst von Anne Davin-Regli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille Univ, INSERM, SSA, MCT, Marseille, France. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactam Resistance, Enterobacteriaceae, Enterobacteriaceae Infections. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Aix-Marseille Univ, INSERM, Service de Santé des Armées.
Abstract (Originalsprache)
In Enterobacteriaceae, susceptibility to cephalosporins and carbapenems is often associated with membrane and enzymatic barrier resistance. For about 20 years, a large number of Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae presenting ß-lactam resistance have been isolated from medical clinics. In addition, some of the resistant isolates exhibited alterations in the outer membrane porin OmpC-OmpF orthologues, resulting in the complete absence of gene expression, replacement by another porin or mutations affecting channel properties. Interestingly, for mutations reported in OmpC-OmpF orthologues, major changes in pore function were found to be present in the gene encoding for OmpC. The alterations were located in the constriction region of the porin and the resulting amino acid substitutions were found to induce severe restriction of the lumen diameter and/or alteration of the electrostatic field that governs the diffusion of charged molecules. This functional adaptation through porins maintains the entry of solutes necessary for bacterial growth but critically controls the influx of harmful molecules such as β-lactams at a reduced cost. The data recently published show the importance of understanding the underlying parameters affecting the uptake of antibiotics by infectious bacteria. Furthermore, the development of reliable methods to measure the concentration of antibiotics within bacterial cells is key to combat impermeability-resistance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aix-Marseille Univ, INSERM, SSA, MCT, Marseille, France.
ORCID-Profile: Julia Vergalli
Förderung
- Aix-Marseille Univ
- INSERM
- Service de Santé des Armées
Zitieren
APA
Davin-Regli, A., Pagès, J. M., & Vergalli, J. (2024). The contribution of porins to enterobacterial drug resistance. Journal of Antimicrobial Chemotherapy, 79(10), 2460-2470. https://doi.org/10.1093/jac/dkae265
Vancouver
Davin-Regli A, Pagès JM, Vergalli J. The contribution of porins to enterobacterial drug resistance. Journal of Antimicrobial Chemotherapy. 2024;79(10):2460-2470. doi:10.1093/jac/dkae265
BibTeX
@article{DavinRegli2024,
author = {Davin-Regli, Anne and Pagès, Jean-Marie and Vergalli, Julia},
title = {The contribution of porins to enterobacterial drug resistance},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
volume = {79},
number = {10},
pages = {2460--2470},
doi = {10.1093/jac/dkae265}
}
EUVIMED